Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

¥27.54As of Sun 8 Nov 2026, 12:00 UTC
SSE:688076Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (14.08%)
Div yield 1.27%
ROE 6.47%
Biotechnology
Beta (5Y) 0.43
PE TTM 39.02
TSR TTM (28.25%)
Mkt cap ¥8.725B
ROIC 9.02%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥28
0.52%
(45.89%)
Hold 8|0|1|6|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.54
0.55
0.60
0.61
4.74%
6.55%
11.43%
17.84%
Revenue¥M
760.7
741.3
775.2
811.7
5.83%
1.73%
1.82%
4.29%
Peers (US$1.308B)
Cap (US$)
PE
1.316B
122.1x
1.280B
130.9x
1.292B
—
Capital
TTM
5Y
10Y
Leveragex
1.255
0.077
0.084
EBIT/Intx
0.328
0.125
0.112
Own earn%
(18.90)
35.28
38.40
Sh yield%
26.50
42.03
38.72
Owners
Insiders/Inst%
8.62
71.99
Short interest%
5.04
SBC / revenue%
5.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
11–15
$1 testx
—
Incr. ROIC%
5